TG Therapeutics, Inc. to Host Conference Call on Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2014 Financial Results and Business Update

NEW YORK, March 10, 2015 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq: TGTX ), today announced that a conference call will be held on Thursday, March 12, 2015 at 8:30am ET to discuss results for the fourth quarter and year-end 2014, and provide a business outlook for 2015. Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.

In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Year-End 2014 Earnings Call.  A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com . An audio recording of the conference call will also be available for replay at www.tgtherapeutics.com , for a period of 30 days after the call.

TG Therapeutics will announce its financial results for this period in a press release to be issued prior to the call.

ABOUT TG THERAPEUTICS, INC.

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B‐lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. The Company also has a pre-clinical program to develop IRAK4 inhibitors, as well as an antibody research program to develop anti-PD-L1 and anti-GITR antibodies. TG Therapeutics is headquartered in New York City.

TGTX - G

Jenna Bosco Director- Investor Relations TG Therapeutics, Inc. Telephone: 212.554.4351 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SKE Capitalizes on Halloween Events in London

Updated Category News Views 143

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 94

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 145

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 138

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 193

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 142

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
A Teen's Opera Encounter Inspires Decades of Passion

Updated Category News Views 94

Unraveling a Lifelong Opera Obsession Back in the dog-eared days of 1970, a teenager waltzed into the Metropolitan Opera and stumbled onto a passion that'd pulse alongside him for over half a century. Now, David E. Lapin rolls out his personal chronicle, 'A Sound Obsession: Fifty-Five Years of Opera at the Met.' Folks, we’re diving into a cultural tapestry that’s...

Continue Reading

Top 5 Most Recently Viewed Articles

RegScale Secures FedRAMP High Authorization: A Game-Changer

Updated Category News Views 263

RegScale Secures FedRAMP High Authorization RegScale, utilizing its innovative Continuous Controls Monitoring platform, has reached the notable milestone of obtaining FedRAMP High Authorization, demonstrating a significant advancement in compliance and risk management within the government sector. This achievement showcases RegScale's commitment to enhancing security...

Continue Reading
SiriusXM Improves Financial Guidance Amid Digital Growth

Updated Category News Views 214

SiriusXM Holdings Inc Experiences Stock Surge SiriusXM Holdings Inc (NASDAQ:SIRI) saw its stock prices climb significantly following the release of its fiscal third-quarter results. Investors responded positively as the company’s future outlook showed promise for expansion. Positive Financial Results The report revealed a subscriber revenue of $1.63 billion for the...

Continue Reading
Explore Top Free AI Image Translators for Your Needs

Updated Category News Views 288

Unlocking the Power of Image Translation Translating text from images is a crucial task in today’s digital world. Whether you need to read signs, understand menus, interpret social media posts, or analyze product reviews, having a reliable image translator can make a significant difference. The right tools not only improve accuracy but also support multiple languages,...

Continue Reading
Exciting Collaboration Unveiled: REESE'S and OREO Join Forces

Updated Category News Views 240

An Exciting New Collaboration The anticipation has been palpable among fans of REESE'S and OREO, and now, the moment has arrived. These iconic brands, celebrated for their unique flavors, are thrilled to present a delectable collaboration that combines their most popular offerings. This partnership responds directly to the enthusiasm and demand expressed by fans....

Continue Reading
Innovative Clinical Research Enhances Care for Cancer Patients

Updated Category News Views 440

Innovative Research at Florida Cancer Specialists Clinical research at Florida Cancer Specialists & Research Institute is making significant strides in expanding treatment options for patients dealing with gastrointestinal and genitourinary cancers. This knowledgeable institute is at the forefront of developing and presenting vital research that contributes to improved...

Continue Reading